Patents by Inventor Steven Greenberg

Steven Greenberg has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240174742
    Abstract: The invention relates to antibodies, or antigen-binding fragments thereof, that specifically binds to interferon beta (IFN?). Such antibodies, or antigen-binding fragments thereof, are are useful for various therapeutic or diagnostic purposes.
    Type: Application
    Filed: November 16, 2023
    Publication date: May 30, 2024
    Inventors: Stefano V. Gulla, Christine Huard, Janet Elizabeth Buhlmann, Juan Carlos Almagro, Sreekumar R. Kodangattil, Steven A. Greenberg, Edward Roland Lavallie, Eric M. Bennett, Lidia Mosyak, James Perry Hall, Anthony John Coyle
  • Patent number: 11858986
    Abstract: The invention relates to antibodies, or antigen-binding fragments thereof, that specifically binds to interferon beta (IFN?). Such antibodies, or antigen-binding fragments thereof, are are useful for various therapeutic or diagnostic purposes.
    Type: Grant
    Filed: November 9, 2020
    Date of Patent: January 2, 2024
    Assignees: Pfizer Inc., The Brigham And Women's Hospital, Inc.
    Inventors: Stefano V. Gulla, Christine Huard, Janet Elizabeth Buhlmann, Juan Carlos Almagro, Sreekumar R. Kodangattil, Steven A. Greenberg, Edward Roland Lavallie, Eric M. Bennett, Lidia Mosyak, James Perry Hall, Anthony John Coyle
  • Patent number: 11671504
    Abstract: Collecting and distributing information related to recent content publication activity of an instant messaging (IM) user provides other users in a network with timely, relevant information about people known to the user or within the same social network. A user participating in a social network can quickly and efficiently perceive new information related to other users (referred to as co-users) in a social network by reviewing the co-users' recent content publication activity. A user may be made able to do so without requiring the co-user to send a communication directly to the user regarding the new facts or new content, and also without requiring the user to actively browse or request information about the co-user.
    Type: Grant
    Filed: May 10, 2019
    Date of Patent: June 6, 2023
    Assignee: Verizon Patent and Licensing Inc.
    Inventors: Christopher Armstrong, Alan Keister, Lark Dunham, Jennifer Granito, Steven Greenberg, Rakesh Agrawal, Michael Sommers, Carol A. Glover
  • Patent number: 11381615
    Abstract: Social network information may be shared across online service providers. Thus, one online service provider M that maintains a membership separate from a second online service provider N may nevertheless use the social network maintained by the second online service provider N to tailor content and/or services base on such social network information.
    Type: Grant
    Filed: December 29, 2020
    Date of Patent: July 5, 2022
    Assignee: Verizon Patent and Licensing Inc.
    Inventors: Barry Appelman, Steven Greenberg
  • Patent number: 11339222
    Abstract: A method of treating a subject can include administering to a subject in need thereof an effective amount of a killer cell lectin-like receptor G1 (KLRG1)/ligand binding agent, thereby disrupting KLRG1 signaling and activating CD8+ cytotoxic T and/or NK cells. A method of treating cancer can include administering to a subject in need thereof an effective amount of a killer cell lectin-like receptor G1 (KLRG1)/ligand binding agent. The methods can treat various cancers, for example melanoma, lung cancer, pancreatic cancer, glioma, breast cancer, and ovarian cancer.
    Type: Grant
    Filed: June 2, 2017
    Date of Patent: May 24, 2022
    Assignee: THE BRIGHAM AND WOMEN'S HOSPITAL, INC.
    Inventors: Steven Greenberg, Stefano Vincenzo Gulla, Kenneth Evan Thompson
  • Publication number: 20210348235
    Abstract: The present invention provides genetic markers on human chromosome 1 that are associated with a beneficial response to CRTH2 receptor antagonists. These CRTH2 receptor antagonist response markers are useful, inter alia, to identify patients who are most likely to benefit from treatment with CRTH2 receptor antagonist compositions and drug products, in methods of treating patients having a disease susceptible to treatment with a CRTH2 receptor antagonist, and in methods for selecting the most appropriate therapy for such patients.
    Type: Application
    Filed: July 16, 2021
    Publication date: November 11, 2021
    Applicant: Merck Sharp & Dohme Corp.
    Inventors: Gregory J. Opiteck, Peggy H. Wong, Joshua McElwee, Devan V. Mehrotra, Steven Greenberg, Zifang Guo
  • Patent number: 11091806
    Abstract: The present invention provides genetic markers on human chromosome 1 that are associated with a beneficial response to CRTH2 receptor antagonists. These CRTH2 receptor antagonist response markers are useful, inter alia, to identify patients who are most likely to benefit from treatment with CRTH2 receptor antagonist compositions and drug products, in methods of treating patients having a disease susceptible to treatment with a CRTH2 receptor antagonist, and in methods for selecting the most appropriate therapy for such patients.
    Type: Grant
    Filed: July 21, 2016
    Date of Patent: August 17, 2021
    Assignee: Merck Sharp & Dohme Corp.
    Inventors: Gregory J. Opiteck, Peggy H. Wong, Joshua McElwee, Devan V. Mehrotra, Steven Greenberg, Zifang Guo
  • Publication number: 20210163588
    Abstract: The invention relates to antibodies, or antigen-binding fragments thereof, that specifically binds to interferon beta (IFN?). Such antibodies, or antigen-binding fragments thereof, are are useful for various therapeutic or diagnostic purposes.
    Type: Application
    Filed: November 9, 2020
    Publication date: June 3, 2021
    Inventors: Stefano V. Gulla, Christine Huard, Janet Elizabeth Buhlmann, Juan Carlos Almagro, Sreekumar R. Kodangattil, Steven A. Greenberg, Edward Roland Lavallie, Eric M. Bennett, Lidia Mosyak, James Perry Hall, Anthony John Coyle
  • Publication number: 20210120052
    Abstract: Social network information may be shared across online service providers. Thus, one online service provider M that maintains a membership separate from a second online service provider N may nevertheless use the social network maintained by the second online service provider N to tailor content and/or services base on such social network information.
    Type: Application
    Filed: December 29, 2020
    Publication date: April 22, 2021
    Inventors: Barry APPELMAN, Steven GREENBERG
  • Patent number: 10911502
    Abstract: Social network information may be shared across online service providers. Thus, one online service provider M that maintains a membership separate from a second online service provider N may nevertheless use the social network maintained by the second online service provider N to tailor content and/or services based on such social network information.
    Type: Grant
    Filed: June 11, 2018
    Date of Patent: February 2, 2021
    Assignee: Verizon Media Inc.
    Inventors: Barry Appelman, Steven Greenberg
  • Patent number: 10855801
    Abstract: Collecting and distributing information related to recent content publication activity of an instant messaging (IM) user provides other users in a network with timely, relevant information about people known to the user or within the same social network. A user participating in a social network can quickly and efficiently perceive new information related to other users (referred to as co-users) in a social network by reviewing the co-users' recent content publication activity. A user may be made able to do so without requiring the co-user to send a communication directly to the user regarding the new facts or new content, and also without requiring the user to actively browse or request information about the co-user.
    Type: Grant
    Filed: August 18, 2014
    Date of Patent: December 1, 2020
    Assignee: Microsoft Technology Licensing, LLC
    Inventors: Christopher Armstrong, Alan Keister, Lark Dunham, Jennifer Granito, Steven Greenberg, Rakesh Agrawal, Michael Sommers, Carol A. Glover
  • Patent number: 10829553
    Abstract: The invention relates to antibodies, or antigen-binding fragments thereof, that specifically binds to interferon beta (IFN?). Such antibodies, or antigen-binding fragments thereof, are useful for various therapeutic or diagnostic purposes.
    Type: Grant
    Filed: April 28, 2017
    Date of Patent: November 10, 2020
    Assignees: PFIZER INC., THE BRIGHAM AND WOMEN'S HOSPITAL, INC.
    Inventors: Stefano V. Gulla, Christine Huard, Janet Elizabeth Buhlmann, Juan Carlos Almagro, Sreekumar R. Kodangattil, Steven A. Greenberg, Edward Roland Lavallie, Eric M. Bennett, Lidia Mosyak, James Perry Hall, Anthony John Coyle
  • Patent number: 10628899
    Abstract: A method for travel planning which includes a customized application and results in efficient customized grouping and coordination of selected locations and destinations based on a combination of user-selected criteria; radius searching; and real-time, simultaneous, multi-source data gathering, analysis, and derivation executed by and presented on a computer or smart device for user preference. At least one embodiment focuses on travel planning for visiting colleges and universities prior to making decisions on where to apply to or where to enroll.
    Type: Grant
    Filed: January 19, 2018
    Date of Patent: April 21, 2020
    Assignee: Nearby Colleges LLC
    Inventor: Eric Steven Greenberg
  • Patent number: 10558681
    Abstract: Embodiments described herein provide enhanced computer- and network-based methods, techniques, and systems for automatically accessing large bodies of potentially disparate data in a compelling environment without the limitations of access provided by spreadsheet systems and in a uniform manner for all types of data. Example embodiments provide an Automated Data Visualization System (“ADVS”), which enables users to access data typically provided by backend systems of organizations in an environment that automatically presents the data using user interface patterns that align with the data. In an example embodiment, the ADVS comprises one or more functional components/modules including an attribute determination logic/engine, a visualization logic/engine, a resizing logic/engine, and a scaling logic/engine in addition to a user interface. Also, in one example embodiment the visualization utilizes a user interface card metaphor to present information.
    Type: Grant
    Filed: January 25, 2017
    Date of Patent: February 11, 2020
    Assignee: Socrata, Inc.
    Inventors: Karin Hellman, Daan Lindhout, Marc Slemko, Jessica Locke, Steven Greenberg, Franklin Williams, Saf Rabah, Giacomo Ferrari, Randy Antler, Marc Millstone, Ben McInnis
  • Publication number: 20190335014
    Abstract: Collecting and distributing information related to recent content publication activity of an instant messaging (IM) user provides other users in a network with timely, relevant information about people known to the user or within the same social network. A user participating in a social network can quickly and efficiently perceive new information related to other users (referred to as co-users) in a social network by reviewing the co-users' recent content publication activity. A user may be made able to do so without requiring the co-user to send a communication directly to the user regarding the new facts or new content, and also without requiring the user to actively browse or request information about the co-user.
    Type: Application
    Filed: May 10, 2019
    Publication date: October 31, 2019
    Inventors: Christopher ARMSTRONG, Alan KEISTER, Lark DUNHAM, Jennifer GRANITO, Steven GREENBERG, Rakesh AGRAWAL, Michael SOMMERS, Carol A. GLOVER
  • Publication number: 20190292264
    Abstract: A method of treating a subject can include administering to a subject in need thereof an effective amount of a killer cell lectin-like receptor G1 (KLRG1)/ligand binding agent, thereby disrupting KLRG1 signaling and activating CD8+ cytotoxic T and/or NK cells. A method of treating cancer can include administering to a subject in need thereof an effective amount of a killer cell lectin-like receptor G1 (KLRG1)/ligand binding agent. The methods can treat various cancers, for example melanoma, lung cancer, pancreatic cancer, glioma, breast cancer, and ovarian cancer.
    Type: Application
    Filed: June 2, 2017
    Publication date: September 26, 2019
    Inventors: Steven Greenberg, Stefano Vincenzo Gulla, Kenneth Evan Thompson
  • Publication number: 20190194333
    Abstract: A method of treating a subject can comprise administering to a subject in need thereof an effective amount of a killer cell lectin-like receptor G1 (KLRG1) depleting agent, thereby depleting CD8+ cytotoxic T and/or NK cells in vivo. A method of treating a subject can comprise administering to a subject in need thereof an effective amount of a KLRG1 depleting agent with effector killing function. A composition, for example an anti-KLRG1 antibody, can comprise a KLRG1 depleting agent. The methods and compositions can be used for various diseases in which KLRG1 is overexpressed, for example autoimmune diseases, transplant rejection, hematologic malignancies, and solid tumors.
    Type: Application
    Filed: September 15, 2017
    Publication date: June 27, 2019
    Inventors: Steven Greenberg, Stefano Vincenzo Gulla, Kenneth Evan Thompson
  • Patent number: 10334071
    Abstract: Collecting and distributing information related to recent content publication activity of an instant messaging (IM) user provides other users in a network with timely, relevant information about people known to the user or within the same social network. A user participating in a social network can quickly and efficiently perceive new information related to other users (referred to as co-users) in a social network by reviewing the co-users' recent content publication activity. A user may be made able to do so without requiring the co-user to send a communication directly to the user regarding the new facts or new content, and also without requiring the user to actively browse or request information about the co-user.
    Type: Grant
    Filed: June 9, 2015
    Date of Patent: June 25, 2019
    Assignee: Oath Inc.
    Inventors: Christopher Armstrong, Alan Keister, Lark Dunham, Jennifer Granito, Steven Greenberg, Rakesh Agrawal, Michael Sommers, Carol A. Glover
  • Publication number: 20190085083
    Abstract: A method of treating a subject can include administering to a subject in need thereof an effective amount of a killer cell lectin-like receptor G1 (KLRG1)/ligand binding agent, thereby disrupting KLRG1 signaling and activating CD8+ cytotoxic T and/or NK cells. A method of treating cancer can include administering to a subject in need thereof an effective amount of a killer cell lectin-like receptor G1 (KLRG1)/ligand binding agent. The methods can treat various cancers, for example melanoma, lung cancer, pancreatic cancer, glioma, breast cancer, ovarian cancer, metastatic breast cancer, and colon cancer.
    Type: Application
    Filed: November 28, 2018
    Publication date: March 21, 2019
    Inventors: Steven Greenberg, Stefano Vincenzo Gulla, Kenneth Evan Thompson
  • Publication number: 20180337965
    Abstract: Social network information may be shared across online service providers. Thus, one online service provider M that maintains a membership separate from a second online service provider N may nevertheless use the social network maintained by the second online service provider N to tailor content and/or services based on such social network information.
    Type: Application
    Filed: June 11, 2018
    Publication date: November 22, 2018
    Inventors: Barry APPELMAN, Steven GREENBERG